West Pharmaceutical

Forecast & Rating16 analysts currently cover West Pharmaceutical, with about 87.5% giving a positive rating — meaning they expect the stock to rise. The average price target is $404.73, about 14.6% upside from the current price of $353.08. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 78.9% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study West Pharmaceutical closely still see room for the stock to rise. Data as of Aug 17, 2026; for reference only and not investment advice.